Campral and Swallowing difficulty - a phase IV clinical study of FDA data

Summary:

Swallowing difficulty is reported as a side effect among people who take Campral (acamprosate calcium), especially for people who are male, 30-39 old, also take Combivent, and have Depression.

The phase IV clinical study analyzes which people have Swallowing difficulty when taking Campral. It is created by eHealthMe based on reports of 820 people who have side effects when taking Campral from the FDA, and is updated regularly.

What is Campral?

Campral has active ingredients of acamprosate calcium. It is often used in alcoholism. eHealthMe is studying from 1,007 Campral users. Check the latest studies of Campral.

What is Swallowing difficulty?

Swallowing difficulty is found to be associated with 2,401 drugs and 3,349 conditions by eHealthMe. Check the latest studies of Swallowing difficulty.

On Jul, 14, 2026

820 people reported to have side effects when taking Campral.
Among them, 12 people (1.46%) have Swallowing difficulty.

Could Campral cause Swallowing difficulty?

Among these 12 people:

What is the gender of people who have Swallowing difficulty when taking Campral? *

female: 8.33 %
male: 91.67 %

What is the age of people who have Swallowing difficulty when taking Campral? *

What are other drugs people take besides Campral? *

What are other side effects people have besides Swallowing difficulty? *

Weight Decreased: 7 people, 58.33%
Dyspnea (difficult or laboured breathing): 7 people, 58.33%
Road Traffic Accident: 5 people, 41.67%
Haematocrit Decreased: 4 people, 33.33%
Malignant Neoplasm Progression (cancer tumour came back): 4 people, 33.33%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 33.33%
Loss Of Consciousness: 4 people, 33.33%
Large Intestinal Ulcer: 4 people, 33.33%
Weakness: 4 people, 33.33%
Intentional Self-Injury: 4 people, 33.33%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 4 people, 33.33%
Depression: 4 people, 33.33%
Urinary Tract Infection: 3 people, 25.00%
Stress And Anxiety: 3 people, 25.00%
Quit Smoking: 3 people, 25.00%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 3 people, 25.00%
Joint Pain: 3 people, 25.00%
High Blood Pressure: 3 people, 25.00%
High Blood Cholesterol: 3 people, 25.00%
Hepatitis C: 3 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Campral and have Swallowing difficulty?

- Check whether Swallowing difficulty is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Campral:

Campral (1,007 reports)

Browse all side effects of Campral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swallowing difficulty:

Swallowing difficulty (2,401 drugs)

Browse all the conditions that are associated with Swallowing difficulty:

Swallowing difficulty (3,349 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acamprosate calcium (the active ingredients of Campral) and Campral (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.